House-dust mite allergy: mapping of Dermatophagoides pteronyssinus allergens for dogs by two-dimensional immunoblotting

Introduction Specific immunotherapy has shown to be very useful for allergy control in dogs, with a common success rate ranging from 65% to 70%. However, this efficacy could probably be improved and the identification of individual allergomes, with the choice of more adequate molecular allergen pools for specific immunotherapy, being the strategy. Aim To map Dermatophagoides pteronyssinus (Der p) allergens for mite-sensitized atopic dogs, for better understanding how individual allergograms may influence the response to house-dust mite immunotherapy. Material and methods To identify the Der p mite allergome for dogs, 20 individuals allergic to dust-mites and sensitized to Der p, were selected. The extract from Der p was submitted to isoelectric focusing (IEF), one-dimensional (1-D) and two-dimensional (2-D) sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Separated proteins were blotted onto polyvinylidene difluoride (PVDF) membranes and immunoblottings were performed with patient sera. Allergen-bound specific IgE was detected. Results Eleven allergens were identified from isoelectric focusing (IEF), as well as from 1-D SDS PAGE. From 2-D SDS-PAGE, 24 spots were identified. Conclusions Several similarities were found between dog and human allergograms and no absolute correlation between sensitization and allergy was observed either. As in humans, different individual allergograms do not seem to implicate different clinical patterns, but may influence the response to specific immunotherapy. The molecular epidemiology approach in veterinary allergy management, by the characterization of individual patients’ allergoms and by choosing the best molecular allergen pool for each patient could also improve the efficacy of allergy immunotherapy.

[1]  L. Burazer,et al.  Immunoproteomic characterization of Ambrosia artemisiifolia pollen allergens in canine atopic dermatitis. , 2013, Veterinary immunology and immunopathology.

[2]  M. Sakaguchi,et al.  IgE reactivity to a Cry j 3, an allergen of Japanese cedar (Cryptomeria japonica) pollen in dogs with canine atopic dermatitis. , 2012, Veterinary immunology and immunopathology.

[3]  G. Pauli,et al.  Mite allergens: an overview. , 2011, European annals of allergy and clinical immunology.

[4]  I. Swoboda,et al.  Molecular characterization of Der p 10: a diagnostic marker for broad sensitization in house dust mite allergy , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  H. Malling,et al.  The current state of recombinant allergens for immunotherapy , 2010, Current opinion in allergy and clinical immunology.

[6]  T. Olivry,et al.  Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. , 2010, Veterinary dermatology.

[7]  T. Olivry New diagnostic criteria for canine atopic dermatitis. , 2010, Veterinary dermatology.

[8]  P. Gamboa,et al.  Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen‐specific immunotherapy , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  D. DeBoer,et al.  Performance characteristics of a monoclonal antibody cocktail-based ELISA for detection of allergen-specific IgE in dogs and comparison with a high affinity IgE receptor-based ELISA. , 2009, Veterinary dermatology.

[10]  M. Leistra,et al.  Dermatophagoides farinae-specific immunotherapy in atopic dogs with hypersensitivity to multiple allergens: a randomised, double blind, placebo-controlled study. , 2009, Veterinary journal.

[11]  H. Ipsen,et al.  Phleum pratense alone is sufficient for allergen‐specific immunotherapy against allergy to Pooideae grass pollens , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  H. Chardin,et al.  Allergome: the characterization of allergens based on a 2D gel electrophoresis approach , 2005, Expert review of proteomics.

[13]  T. Nuttall,et al.  Prevalence of the group 1 Dermatophagoides allergens Der p 1 and Der f 1 in homes with no dogs, healthy dogs and Dermatophagoides-sensitized atopic dogs in Liverpool. , 2005, Veterinary dermatology.

[14]  G. Peltre,et al.  The Helix aspersa (Brown Garden Snail) Allergen Repertoire , 2005, International Archives of Allergy and Immunology.

[15]  M. W. Mueller,et al.  Allergen microarray: comparison of microarray using recombinant allergens with conventional diagnostic methods to detect allergen‐specific serum immunoglobulin E , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  Marek Jutel,et al.  IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy , 2003, European journal of immunology.

[17]  J. Lamb,et al.  Characterisation of major and minor Dermatophagoides allergens in canine atopic dermatitis. , 2001, Research in veterinary science.

[18]  T. Olivry,et al.  Characterization and cloning of a major high molecular weight house dust mite allergen (Der f 15) for dogs. , 2001, Veterinary immunology and immunopathology.

[19]  A. Hasegawa,et al.  IgE sensitivity and cross-reactivity to crude and purified mite allergens (Der f 1, Der f 2, Der p 1, Der p 2) in atopic dogs sensitive to Dermatophagoides mite allergens. , 1999, Veterinary immunology and immunopathology.

[20]  Niederberger,et al.  The recombinant allergen‐based concept of component‐resolved diagnostics and immunotherapy (CRD and CRIT) , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  G. Peltre,et al.  Mapping of Dermatophagoides farinae mite allergens by two-dimensional immunoblotting. , 1998, The Journal of allergy and clinical immunology.

[22]  E. Tan,et al.  Hypersensitivity reactions , 1974, Clinical pharmacology and therapeutics.

[23]  M. Fernández-Rivas,et al.  Immunotherapy with a Phleum pratense allergen extract induces an immune response to a grass-mix allergen extract. , 2010, Journal of investigational allergology & clinical immunology.

[24]  R. Niessner,et al.  Detection of known allergen-specific IgE antibodies by immunological methods. , 2009, Methods in molecular biology.

[25]  I. Postigo,et al.  Contribution of molecular diagnosis of allergy to the management of pediatric patients with allergy to pollen. , 2009, Journal of investigational allergology & clinical immunology.

[26]  Reiner Westermeier,et al.  Electrophoresis In Practice , 1993 .

[27]  M. Mardiney,et al.  Dose response of IgE and IgG antibodies during ragweed immunotherapy. , 1984, The Journal of allergy and clinical immunology.